BioWorld

July 29, 2003

Clusterin Protein May Improve Important, Lifesaving Early Colon Cancer Call Over Colonoscopy

OxiGene Gets Orphan Status For CA4P; Stock Soars 50 Percent

Other News To Note

MGI Offering Could Gross $128M Following FDA Approval Of Aloxi

Capitalizing on a stock surge prompted by Friday's approval of a partnered cancer drug, MGI Pharma Inc. on Monday reported plans to sell 4 million shares. (BioWorld Today) Read More

ISTA Gets Approvable Letter On Product To Treat Glaucoma

Today's news in brief

BioWorld

BioWorld briefs for Dec. 11, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 11, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

US lawmakers demand that Kennedy be held accountable

BioWorld

As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...

Medline plans record-setting $5.37B IPO

BioWorld MedTech

Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...